Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
PLoS One. 2022 Sep 29;17(9):e0267906. doi: 10.1371/journal.pone.0267906. eCollection 2022.
There is a scarcity of studies comparing percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES) with coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease.
The CREDO-Kyoto PCI/CABG registry Cohort-3 enrolled 14927 consecutive patients who underwent first coronary revascularization with PCI or isolated CABG between January 2011 and December 2013. The current study population consisted of 2464 patients who underwent multi-vessel coronary revascularization including revascularization of left anterior descending coronary artery (LAD) either with PCI using new-generation DES (N = 1565), or with CABG (N = 899). Patients in the PCI group were older and more often had severe frailty, but had less complex coronary anatomy, and less complete revascularization than those in the CABG group. Cumulative 5-year incidence of a composite of all-cause death, myocardial infarction or stroke was not significantly different between the 2 groups (25.0% versus 21.5%, P = 0.15). However, after adjusting confounders, the excess risk of PCI relative to CABG turned to be significant for the composite endpoint (HR 1.27, 95%CI 1.04-1.55, P = 0.02). PCI as compared with CABG was associated with comparable adjusted risk for all-cause death (HR 1.22, 95%CI 0.96-1.55, P = 0.11), and stroke (HR 1.17, 95%CI 0.79-1.73, P = 0.44), but with excess adjusted risk for myocardial infarction (HR 1.58, 95%CI 1.05-2.39, P = 0.03), and any coronary revascularization (HR 2.66, 95%CI 2.06-3.43, P<0.0001).
In this observational study, PCI with new-generation DES as compared with CABG was associated with excess long-term risk for major cardiovascular events in patients who underwent multi-vessel coronary revascularization including LAD.
比较新一代药物洗脱支架(DES)经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)治疗多支血管病变的研究较少。
CREDO-Kyoto PCI/CABG 注册研究队列 3 纳入了 14927 例 2011 年 1 月至 2013 年 12 月期间首次接受 PCI 或单独 CABG 冠状动脉血运重建的连续患者。本研究人群包括 2464 例接受多支血管血运重建的患者,其中 1565 例接受新一代 DES 行 PCI(N=1565),899 例接受 CABG(N=899)。与 CABG 组相比,PCI 组患者年龄更大,衰弱程度更严重,但冠状动脉解剖结构更简单,血运重建程度更低。两组 5 年全因死亡、心肌梗死或卒中的复合终点发生率无显著差异(25.0%比 21.5%,P=0.15)。然而,在校正混杂因素后,PCI 相对于 CABG 的复合终点风险增加具有显著统计学意义(HR 1.27,95%CI 1.04-1.55,P=0.02)。与 CABG 相比,PCI 与全因死亡(HR 1.22,95%CI 0.96-1.55,P=0.11)和卒中(HR 1.17,95%CI 0.79-1.73,P=0.44)的调整后风险相当,但与心肌梗死(HR 1.58,95%CI 1.05-2.39,P=0.03)和任何冠状动脉血运重建(HR 2.66,95%CI 2.06-3.43,P<0.0001)的调整后风险增加相关。
在这项观察性研究中,与 CABG 相比,新一代 DES 行 PCI 与多支血管血运重建(包括左前降支)患者的主要心血管事件长期风险增加相关。